Chaitanya G V, Franks S E, Cromer W, Wells S R, Bienkowska M, Jennings M H, Ruddell A, Ando T, Wang Y, Gu Y, Sapp M, Mathis J M, Jordan P A, Minagar A, Alexander J S
Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130-3932, USA.
Lymphat Res Biol. 2010 Sep;8(3):155-64. doi: 10.1089/lrb.2010.0004.
Inflammatory cytokines dysregulate microvascular function, yet how cytokines affect lymphatic endothelial cells (LEC) are unclear.
We examined effects of TNF-α, IL-1 beta, and IFN-gamma on LEC proliferation, endothelial cell adhesion molecule (ECAM) expression, capillary formation, and barrier changes in murine (SV-LEC) and human LECs (HMEC-1a).
All cytokines induced ICAM-1, VCAM-1, MAdCAM-1, and E-selectin in SV-LECs; TNF-α, IL-1 beta; and IFN-gamma induced ECAMs (but not MAdCAM-1) in HMEC-1a. IL-1 beta increased, while IFN-gamma and TNF-α reduced SV-LEC proliferation. While TNF-α induced, IFN-gamma decreased, and IL-1 beta did not show any effect on HMEC-1a proliferation. TNF-α, IL-1 beta, and IFN-gamma each reduced capillary formation in SV-LEC and in HMEC-1a. TNF-α and IL-1 beta reduced barrier in SV-LEC and HMEC-1a; IFN-gamma did not affect SV-LEC barrier, but enhanced HMEC-1a barrier. Inflammatory cytokines alter LEC growth, activation and barrier function in vitro and may disturb lymphatic clearance increasing tissue edema in vivo.
Therapies that maintain or restore lymphatic function (including cytokines blockade), may represent important strategies for limiting inflammation.
炎性细胞因子会使微血管功能失调,但细胞因子如何影响淋巴管内皮细胞(LEC)尚不清楚。
我们研究了肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和干扰素-γ(IFN-γ)对小鼠淋巴管内皮细胞(SV-LEC)和人淋巴管内皮细胞(HMEC-1a)的增殖、内皮细胞黏附分子(ECAM)表达、毛细血管形成及屏障变化的影响。
所有细胞因子均可诱导SV-LEC表达细胞间黏附分子-1(ICAM-1)、血管细胞黏附分子-1(VCAM-1)、黏膜地址素细胞黏附分子-1(MAdCAM-1)和E-选择素;TNF-α、IL-1β和IFN-γ可诱导HMEC-1a表达ECAM(但不包括MAdCAM-1)。IL-1β可促进SV-LEC增殖,而IFN-γ和TNF-α则抑制其增殖。TNF-α可诱导HMEC-1a增殖,IFN-γ则抑制其增殖,IL-1β对HMEC-1a增殖无影响。TNF-α、IL-1β和IFN-γ均可减少SV-LEC和HMEC-1a的毛细血管形成。TNF-α和IL-1β可降低SV-LEC和HMEC-1a的屏障功能;IFN-γ不影响SV-LEC的屏障功能,但可增强HMEC-1a的屏障功能。炎性细胞因子在体外可改变LEC的生长、活化及屏障功能,并可能干扰淋巴清除,导致体内组织水肿。
维持或恢复淋巴功能的疗法(包括细胞因子阻断)可能是限制炎症的重要策略。